Humanized mouse antibody: Filed IND and plans to begin Phase I trials.

Icos Corp. (ICOS), Seattle Product: Humanized mouse antibody targeting leukointegrin on white blood cells Indication: Multiple sclerosis Status: Filed IND and plans to begin Phase I trials in the firs...